Oncology Venture US Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.75M

Oncology Venture US General Information

Description

Developer of medical therapeutics designed to treat cancer in women. The company's medical therapeutics includes drug candidates focused on breast, ovarian, and endometrial cancers and primary and secondary brain tumors and offers demonstrated validated clinical responses and uses proprietary biomarker drug response predictor technology to significantly increase response rates, thereby enabling doctors to help patients recover faster.

Contact Information

Formerly Known As
2X Oncology
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Corporate Office
  • 210 Broadway
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 210 Broadway
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncology Venture US Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 13-Jul-2020 $1.75M Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 31-May-2017 Cancelled Clinical Trials - Phase 2
1. Seed Round 30-Dec-2016 $3.5M $3.5M Completed Clinical Trials - Phase 2
To view Oncology Venture US’s complete valuation and funding history, request access »

Oncology Venture US Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Oncology Venture US’s complete cap table history, request access »

Oncology Venture US Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncology Venture US Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sass & Larsen Corporation Minority
To view Oncology Venture US’s complete investors history, request access »

Oncology Venture US FAQs

  • When was Oncology Venture US founded?

    Oncology Venture US was founded in 2015.

  • Where is Oncology Venture US headquartered?

    Oncology Venture US is headquartered in Cambridge, MA.

  • What is the size of Oncology Venture US?

    Oncology Venture US has 9 total employees.

  • What industry is Oncology Venture US in?

    Oncology Venture US’s primary industry is Drug Discovery.

  • Is Oncology Venture US a private or public company?

    Oncology Venture US is a Private company.

  • What is the current valuation of Oncology Venture US?

    The current valuation of Oncology Venture US is .

  • What is Oncology Venture US’s current revenue?

    The current revenue for Oncology Venture US is .

  • How much funding has Oncology Venture US raised over time?

    Oncology Venture US has raised $3.5M.

  • Who are Oncology Venture US’s investors?

    Sass & Larsen has invested in Oncology Venture US.

  • When was Oncology Venture US acquired?

    Oncology Venture US was acquired on 13-Jul-2020.

  • Who acquired Oncology Venture US?

    Oncology Venture US was acquired by Allarity Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process